Skip to content

Innate immunity and vascular complications in type II diabetic South-Asian immigrants

Innate immunity and vascular complications in type II diabetic South-Asian immigrants - Hindinef II

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30311
Enrollment
169
Registered
2007-05-14
Start date
2007-03-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease diabetes nephropathy retinopathy

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diabetes type II

Exclusion criteria

Exclusion criteria: geen

Design outcomes

Primary

MeasureTime frame
- prevalence / progression nephropathy - prevalence retinopathy - prevalence ischemic heart disease - prevalence peripheral vascular disease - prevalence cerebral vascular accidents - intima media thickness of the carotid artery - pulse wave velocity analysis

Secondary

MeasureTime frame
no

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)